Skip to product information
1 of 1

Valuemed

ALLTEST Professional CA15-3 Breast Cancer Rapid Test Cassette 10 Test Pack

ALLTEST Professional CA15-3 Breast Cancer Rapid Test Cassette 10 Test Pack

Regular price £49.99 GBP
Regular price Sale price £49.99 GBP
Sale Sold out
Tax included. Shipping calculated at checkout.

Out of stock

Please note this is a professional medical test kit intended solely for use by healthcare professionals. It is not a home test kit. The equipment for obtaining the blood sample is not provided with the test kits. 

CA 15-3 test kit for breast cancer

CA15-3 is the one of the most widely used biomarker for Breast Cancer diagnosis.

ALLTEST CA15-3 test cassettes

The ALLTEST ca 15-3 test kit for breast cancer is to be used for venous whole blood, serum and plasma allow instant onsite identification of elevated CA15-3 levels of 30U/ml and over, as a marker of Breast Cancer Disease.

This is a professional CA15-3 Rapid Test for GP's Health Screening and Hospitals. The CA15-3 Rapid Test Device detects CA15-3 at 30U/ml and over in human blood samples providing on-site results in 10 minutes.

ALLTEST CA 15-3 test kit for breast cancer pack contents:

  • Pack of 10 test kits
  • 1 buffer 1 data sheet instruction.

Key features of the ALLTEST CA 15-3 test kit for breast cancer

  • Each test kit contains everything needed for a complete CA 15-3 test kit for breast cancer test -
  • This test is for professional use only ie GP surgeries, clinics, laboratories, occupational health and by healthcare professionals.
  • The packs are suitable for venous whole blood samples stored using standard anti-coagulants. Tests suitable for capillary blood samples but no 75u/l transfer tubes are provided.
  • The ALLTEST CA15-3 rapid test can detect as low as 30U/ml
  • Over 98.3% overall accuracy
  • This is a professional medical diagnostic test kit intended solely for use by healthcare professionals.

Main uses of the CA 15-3 test kit

Monitoring breast cancer treatment

  • To assess how well a person with advanced breast cancer is responding to treatment (e.g. chemotherapy, hormone therapy).
  • falling CA 15-3 level may suggest that treatment is working, while a rising level could indicate progression.

Checking for recurrence

  • After initial breast cancer treatment, CA 15-3 may be monitored over time to detect any early signs of recurrence.

Assessing prognosis

  • Elevated CA 15-3 levels at diagnosis may be associated with more extensive disease and a worse prognosis.

CA15-3 test is not typically used for:

  • It’s not recommended for breast cancer screening or diagnosis on its own.
  • Not all breast cancers produce CA 15-3, so it’s not useful in every case.
  • Also used less commonly in some other cancers like ovarian, lung, or pancreatic cancers.

CA 15-3 levels can be elevated in several non-cancerous (benign) conditions, as well as in some other types of cancer. This is why it’s always important to interpret results in context, alongside other tests and clinical findings.

Non-cancerous conditions that may cause raised CA 15-3 levels

  • Benign breast disease (e.g. fibrocystic changes)
  • Benign ovarian cysts
  • Liver disease (including hepatitis and cirrhosis)
  • Lung conditions (e.g. sarcoidosis)
  • Autoimmune diseases (e.g. systemic lupus erythematosus)
  • Endometriosis

Other cancers that may raise CA 15-3 (usually not as high as in breast cancer)

  • Ovarian cancer
  • Lung cancer
  • Pancreatic cancer
  • Colorectal cancer
  • Liver cancer
  • Prostate cancer

Because of this lack of specificity, CA 15-3 is not usually used as a diagnostic tool on its own but rather as part of ongoing monitoring in known breast cancer cases.

View full details

Collapsible content

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)